UniProt ID | U2AFM_HUMAN | |
---|---|---|
UniProt AC | Q15696 | |
Protein Name | U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 | |
Gene Name | ZRSR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 482 | |
Subcellular Localization | Nucleus . | |
Protein Description | Pre-mRNA-binding protein required for splicing of both U2- and U12-type introns. Selectively interacts with the 3'-splice site of U2- and U12-type pre-mRNAs and promotes different steps in U2 and U12 intron splicing. Recruited to U12 pre-mRNAs in an ATP-dependent manner and is required for assembly of the prespliceosome, a precursor to other spliceosomal complexes. For U2-type introns, it is selectively and specifically required for the second step of splicing.. | |
Protein Sequence | MAAPEKMTFPEKPSHKKYRAALKKEKRKKRRQELARLRDSGLSQKEEEEDTFIEEQQLEEEKLLERERQRLHEEWLLREQKAQEEFRIKKEKEEAAKKRQEEQERKLKEQWEEQQRKEREEEEQKRQEKKEKEEALQKMLDQAENELENGTTWQNPEPPVDFRVMEKDRANCPFYSKTGACRFGDRCSRKHNFPTSSPTLLIKSMFTTFGMEQCRRDDYDPDASLEYSEEETYQQFLDFYEDVLPEFKNVGKVIQFKVSCNLEPHLRGNVYVQYQSEEECQAALSLFNGRWYAGRQLQCEFCPVTRWKMAICGLFEIQQCPRGKHCNFLHVFRNPNNEFWEANRDIYLSPDRTGSSFGKNSERRERMGHHDDYYSRLRGRRNPSPDHSYKRNGESERKSSRHRGKKSHKRTSKSRERHNSRSRGRNRDRSRDRSRGRGSRSRSRSRSRRSRRSRSQSSSRSRSRGRRRSGNRDRTVQSPKSK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
40 | Phosphorylation | ELARLRDSGLSQKEE HHHHHHHCCCCHHHH | 34.89 | 28348404 | |
43 | Phosphorylation | RLRDSGLSQKEEEED HHHHCCCCHHHHHHC | 42.61 | 28348404 | |
45 | Sumoylation | RDSGLSQKEEEEDTF HHCCCCHHHHHHCCH | 64.81 | 28112733 | |
51 | Phosphorylation | QKEEEEDTFIEEQQL HHHHHHCCHHHHHHH | 29.77 | 30257219 | |
62 | Ubiquitination | EQQLEEEKLLERERQ HHHHHHHHHHHHHHH | 62.75 | 29967540 | |
62 | Sumoylation | EQQLEEEKLLERERQ HHHHHHHHHHHHHHH | 62.75 | 28112733 | |
66 | Ubiquitination | EEEKLLERERQRLHE HHHHHHHHHHHHHHH | 44.35 | 24816145 | |
92 | Ubiquitination | EFRIKKEKEEAAKKR HHHHHHHHHHHHHHH | 70.50 | 24816145 | |
130 | Ubiquitination | EQKRQEKKEKEEALQ HHHHHHHHHHHHHHH | 73.58 | - | |
132 | Ubiquitination | KRQEKKEKEEALQKM HHHHHHHHHHHHHHH | 70.50 | - | |
138 | Ubiquitination | EKEEALQKMLDQAEN HHHHHHHHHHHHHHH | 42.13 | - | |
177 | Ubiquitination | ANCPFYSKTGACRFG CCCCCCCCCCCCCCC | 39.33 | - | |
207 | Phosphorylation | LLIKSMFTTFGMEQC EHHHHHHHHHCHHHH | 16.75 | - | |
252 | Ubiquitination | PEFKNVGKVIQFKVS HHHCCCCCEEEEEEE | 31.70 | 29967540 | |
347 | Phosphorylation | WEANRDIYLSPDRTG HHHCCCEEECCCCCC | 12.86 | 22167270 | |
349 | Phosphorylation | ANRDIYLSPDRTGSS HCCCEEECCCCCCCC | 14.05 | 19664994 | |
353 | Phosphorylation | IYLSPDRTGSSFGKN EEECCCCCCCCCCCC | 49.12 | 23927012 | |
355 | Phosphorylation | LSPDRTGSSFGKNSE ECCCCCCCCCCCCHH | 23.14 | 23927012 | |
356 | Phosphorylation | SPDRTGSSFGKNSER CCCCCCCCCCCCHHH | 39.09 | 23927012 | |
361 | Phosphorylation | GSSFGKNSERRERMG CCCCCCCHHHHHHHC | 35.65 | 28555341 | |
374 | Phosphorylation | MGHHDDYYSRLRGRR HCCCHHHHHHHCCCC | 8.36 | - | |
384 | Phosphorylation | LRGRRNPSPDHSYKR HCCCCCCCCCCCCCC | 46.65 | 21955146 | |
388 | Phosphorylation | RNPSPDHSYKRNGES CCCCCCCCCCCCCCC | 39.46 | 23403867 | |
389 | Phosphorylation | NPSPDHSYKRNGESE CCCCCCCCCCCCCCC | 15.56 | 23403867 | |
420 | Phosphorylation | KSRERHNSRSRGRNR HHHHHHHHHHCCCCC | 26.05 | 26270265 | |
430 | Phosphorylation | RGRNRDRSRDRSRGR CCCCCCHHHHHCCCC | 42.70 | 20068231 | |
434 | Phosphorylation | RDRSRDRSRGRGSRS CCHHHHHCCCCCCHH | 43.29 | 20068231 | |
439 | Phosphorylation | DRSRGRGSRSRSRSR HHCCCCCCHHHHHHH | 26.23 | 20068231 | |
441 | Phosphorylation | SRGRGSRSRSRSRSR CCCCCCHHHHHHHHH | 35.98 | 20068231 | |
457 | Phosphorylation | SRRSRSQSSSRSRSR HHHHHHHHHHHHHHH | 31.37 | 24260401 | |
458 | Phosphorylation | RRSRSQSSSRSRSRG HHHHHHHHHHHHHHC | 23.33 | 24260401 | |
475 | Phosphorylation | RSGNRDRTVQSPKSK CCCCCCCCCCCCCCC | 27.47 | 26546556 | |
478 | Phosphorylation | NRDRTVQSPKSK--- CCCCCCCCCCCC--- | 29.93 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of U2AFM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of U2AFM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of U2AFM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349 AND SER-384, ANDMASS SPECTROMETRY. |